Tim Evans
Stock Analyst at Wells Fargo
(1.73)
# 1,958
Out of 4,479 analysts
19
Total ratings
76.92%
Success rate
10.56%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTLT Catalent | Maintains: Equal-Weight | $50 → $42 | $56.20 | -25.27% | 3 | Nov 16, 2023 | |
| MEDP Medpace Holdings | Maintains: Market Perform | n/a | $404.42 | - | 2 | Feb 28, 2018 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | n/a | $267.55 | - | 2 | Feb 28, 2018 | |
| ILMN Illumina | Upgrades: Outperform | n/a | $105.51 | - | 2 | Jan 2, 2018 | |
| WST West Pharmaceutical Services | Maintains: Outperform | n/a | $322.60 | - | 1 | Oct 27, 2017 | |
| DGX Quest Diagnostics | Maintains: Market Perform | n/a | $136.64 | - | 2 | Oct 20, 2017 | |
| LH Labcorp Holdings | Reinstates: Outperform | n/a | $202.73 | - | 1 | Oct 12, 2017 | |
| TECH Bio-Techne | Initiates: Market Perform | n/a | $71.24 | - | 1 | Jul 13, 2017 | |
| DHR Danaher | Initiates: Market Perform | n/a | $240.41 | - | 1 | Jul 13, 2017 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | n/a | $1,357.07 | - | 1 | Jul 13, 2017 | |
| BRKR Bruker | Downgrades: Underperform | n/a | $61.64 | - | 1 | Jul 13, 2017 | |
| A Agilent Technologies | Upgrades: Outperform | n/a | $125.78 | - | 1 | Jul 13, 2017 | |
| INCR InterCure | Downgrades: Market Perform | n/a | $2.05 | - | 1 | May 3, 2017 |
Catalent
Nov 16, 2023
Maintains: Equal-Weight
Price Target: $50 → $42
Current: $56.20
Upside: -25.27%
Medpace Holdings
Feb 28, 2018
Maintains: Market Perform
Price Target: n/a
Current: $404.42
Upside: -
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: n/a
Current: $267.55
Upside: -
Illumina
Jan 2, 2018
Upgrades: Outperform
Price Target: n/a
Current: $105.51
Upside: -
West Pharmaceutical Services
Oct 27, 2017
Maintains: Outperform
Price Target: n/a
Current: $322.60
Upside: -
Quest Diagnostics
Oct 20, 2017
Maintains: Market Perform
Price Target: n/a
Current: $136.64
Upside: -
Labcorp Holdings
Oct 12, 2017
Reinstates: Outperform
Price Target: n/a
Current: $202.73
Upside: -
Bio-Techne
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $71.24
Upside: -
Danaher
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $240.41
Upside: -
Mettler-Toledo International
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1,357.07
Upside: -
Bruker
Jul 13, 2017
Downgrades: Underperform
Price Target: n/a
Current: $61.64
Upside: -
Agilent Technologies
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $125.78
Upside: -
InterCure
May 3, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $2.05
Upside: -